Antitrypsin Deficiency News and Research

RSS
Opportunities and risks of direct-to-consumer genetic health risk tests

Opportunities and risks of direct-to-consumer genetic health risk tests

FDA authorizes marketing of first direct-to-consumer GHR tests for certain diseases

FDA authorizes marketing of first direct-to-consumer GHR tests for certain diseases

Exosome isolation using ultracentrifugation

Exosome isolation using ultracentrifugation

RNA silencing technique developed by spinoff from UM-Madison effective in battling hepatitis B

RNA silencing technique developed by spinoff from UM-Madison effective in battling hepatitis B

New lung-targeted gene therapy shows promise in improving treatment for emphysema

New lung-targeted gene therapy shows promise in improving treatment for emphysema

New RNA aptamer can prevent pathogenic protein misfolding

New RNA aptamer can prevent pathogenic protein misfolding

Innovative approach to treating AAT deficiency

Innovative approach to treating AAT deficiency

Therapy for genetically-caused emphysema slows progression of lung disease

Therapy for genetically-caused emphysema slows progression of lung disease

Alnylam files clinical trial application for alpha-1 liver disease, presents data at DDW

Alnylam files clinical trial application for alpha-1 liver disease, presents data at DDW

New Breathe NIOV System uses Bayer’s injection-molded Makrolon polycarbonate

New Breathe NIOV System uses Bayer’s injection-molded Makrolon polycarbonate

Dr. Hans Clevers receives ISSCR's McEwen Award for Innovation

Dr. Hans Clevers receives ISSCR's McEwen Award for Innovation

Johns Hopkins scientists use genome editing technology to alter human stem cells

Johns Hopkins scientists use genome editing technology to alter human stem cells

TSRI study examines body’s own response against chronic protein misfolding

TSRI study examines body’s own response against chronic protein misfolding

Kamada announces top-line results from Phase II/III trial for treatment of inherited emphysema

Kamada announces top-line results from Phase II/III trial for treatment of inherited emphysema

Kamada to present Phase 2/3 clinical trial results of AAT to treat alpha-1 antitrypsin deficiency

Kamada to present Phase 2/3 clinical trial results of AAT to treat alpha-1 antitrypsin deficiency

FDA grants clearance for Breathe Technologies’ Non-Invasive Open Ventilation System

FDA grants clearance for Breathe Technologies’ Non-Invasive Open Ventilation System

Baxter plans to create two independent global healthcare companies

Baxter plans to create two independent global healthcare companies

SLU researchers receive $1.4M grant to study alpha-1 antitrypsin deficiency in adults

SLU researchers receive $1.4M grant to study alpha-1 antitrypsin deficiency in adults

Drug used to treat schizophrenia, dementia has potential for treating liver disease

Drug used to treat schizophrenia, dementia has potential for treating liver disease

UMMS researchers commissioned by Alpha-1 Project to develop PiZ antibody

UMMS researchers commissioned by Alpha-1 Project to develop PiZ antibody